TradingAgents AISign inGet started
All stock profiles
NORDNASDAQHealthcare

NORDICUS PARTNERS CORP

Public company snapshot, recent ticker-linked headlines, and a path into evidence-backed AI research.

Latest price

$4.91

-3.52%

Alpha Vantage · 10/30/2026

Industry: BiotechnologyCategory: Domestic Common StockCurrency: USDNews: 0 recent
Analyze NORD free

One-year price history

Adjusted daily closes · 252 observations · as of Oct 30, 2026

Historical data, not a forecast

1 month

+22.8%

3 months

+118.2%

6 months

+24.3%

1 year

-1.8%

Year to date

-1.8%

52-week range

$1.63 – $5.09

Fundamental snapshot

Latest reported period: Jun 30, 2026

Sharadar reported data

Market cap

$95.5M

P/E

-18.8

P/B

1.6

P/S

—

Revenue

$0

Net income

-$5.07M

Diluted EPS

-0.28

Gross margin

—

Net margin

—

Return on equity

-7.90%

Total debt

$82K

Cash

$5.78K

Free cash flow

-$4.07M

Latest eight reported quarters

Reported quarterly values, newest first

PeriodRevenueNet incomeGross marginNet marginFree cash flow
Jun 30, 2026$0-$2.28M——-$161.02K
Mar 31, 2026$0-$56.11K——-$673.21K
Dec 31, 2025$0-$1.23M——-$1.46M
Sep 30, 2025$0-$1.51M——-$1.77M
Jun 30, 2025$0-$1.21M——-$425.7K
Mar 31, 2025$0-$606.4K——-$385.1K
Dec 31, 2024$2.5K-$1.54M100.00%-61438.50%-$299.65K
Sep 30, 2024$2.5K-$500.79K100.00%-20031.40%$216.95M

Reported figures can reflect company reporting conventions, restatements, or sector-specific accounting. Verify against filings before relying on a valuation comparison.

Recent NORD news

All market news

No ticker-linked stories are in the current archive.